Technology | EP Mapping and Imaging Systems
Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a product designed to advance cardiac mapping during cardiac ablation to treat patients with complex cardiac arrhythmias. With the European launch of this latest addition to Abbott’s electrophysiology portfolio, the company is offering physicians a mapping catheter with what it calls a first-of-its-kind grid configuration of electrodes for improved data collection that supports the creation of high-density mapping of cardiac tissue to support optimal treatment for patients.
January 19, 2018
The U.S. Food and Drug Administration (FDA) announced that International Laboratories LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel Tablets USP, 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg.
January 19, 2018
Feature | Clinical Decision Support
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader in ...
January 18, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Stents Bifurcation
January 18, 2018 – West Hills Hospital & Medical Center, a full-service acute care facility, announces the first ...
January 18, 2018
January 18, 2018 – Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc., a worldwide leader ...
January 18, 2018
Blog | TCT
Here is a list of what I think were some of the top interventional technologies discussed at the 2017 Transcatheter ...
January 18, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Stents Drug Eluting | Dave Fornell
There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or ...
January 17, 2018
Technology | Cardiac Imaging
Philips recently announced the launch of Technology Maximizer, a cross-modality program designed to boost the clinical capabilities and performance of imaging equipment through proactive upgrades. Technology Maximizer provides confidence to radiology and cardiology department leaders and clinicians that their systems are up to date and compliant at a fraction of the cost of individual upgrades, according to Philips.
January 17, 2018
News | Cardiovascular Ultrasound
The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and Medstreaming-M2S announced the development of the Vascular Quality Initiative (VQI) Vascular Ultrasound Registry. This Registry represents an expansion of the SVS VQI, which will combine noninvasive (vascular ultrasound) testing data with vascular treatment and outcomes data, making it possible to analyze the relationships between diagnosis and care provided to patients with vascular disease.
January 17, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Stem Cell Therapies
Secant Group, in partnership with its sister company SanaVita Medical, announced new technology to advance cardiovascular regenerative medicine with the development of a synthetic, small-bore vessel that encourages endogenous regeneration and new vessel formation. The technology is based on the company’s textile forming capabilities that can produce a hollow lumen construct infused with Secant’s proprietary Regenerez bioresorbable polymer technology. The new small-bore vessel supports the regeneration of new vascular tissue structures without the need for cell seeding or biologic growth promoters.
January 17, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have ...
January 16, 2018
News | Hemodynamic Support Devices
Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) announced the closing of €25m as part of a Series D financing round. The new capital will be used to further develop and commercialize the PiCSO Impulse System. The round was led by Ming Capital (Shenzhen, China) and co-led by a strategic investor.
January 16, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News | Cardiovascular Business
American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be leaving the College effective Feb. 2, 2018, to lead CiVi Biopharma Inc., a privately held biopharmaceutical company. Cathy Gates, ACC chief operating officer and executive vice president, will serve as interim CEO.
January 16, 2018
Technology | Atherectomy Devices
Medtronic plc announced the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide Aspiration System, adding a tool to its acute ischemic stroke (AIS) product portfolio.
January 16, 2018
Feature | Atrial Fibrillation | Dave Fornell
The development of atrial fibrillation (AFib or AF) ablation technologies over the past 20 years has been a constant ...
January 15, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now